Scheibler Lukas has sold 69,643 shares of Apellis Pharmaceuticals, Inc. [APLS] at $58.50 a share.
Apellis Pharmaceuticals, Inc. [APLS] disclosed in an SEC Form 4 submission Tuesday, February 21, 2023 that the deal increased Scheibler Lukas's holding in the company to 715.
Apellis Pharmaceuticals, Inc. [APLS] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.